Brief: Oasmia Q1 Operating Loss Narrows To SEK 40.8 Mln
27/05/2021 07:09
May 27 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* INTERIM REPORT FOR THE PERIOD JANUARY 1, 2021 – MARCH 31,
2021
* Q1 CONSOLIDATED NET SALES AMOUNTED TO TSEK 37 (201,220)
* Q1 OPERATING LOSS WAS TSEK -40,843 (128,607)
Source text for Eikon: ID:nMFN4BDKZP
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))